Recent research has placed increasing importance on identifying mechanisms regulating adipose tissue function and adipokine secretion as potential therapeutic targets in metabolic diseases (although adiponectin remains the best-studied and described adipokine). This evidence concerns the gene ADIPOQ and metabolic disease.